As of 2024-07-27, the Relative Valuation of Knight Therapeutics Inc (GUD.TO) is (0.01) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 5.68 CAD, the upside of Knight Therapeutics Inc based on Relative Valuation is -100.2%.
The range of the Relative Valuation is (0.00) - (0.01) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.0x - 0.1x | 0.0x |
| Forward P/E multiples | - | - |
| Fair Price | (0.00) - (0.01) | (0.01) |
| Upside | -100.1% - -100.2% | -100.2% |
| Date | P/E |
| 2024-07-26 | -33.17 |
| 2024-07-25 | -32.99 |
| 2024-07-24 | -32.47 |
| 2024-07-23 | -33.05 |
| 2024-07-22 | -33.11 |
| 2024-07-19 | -33.28 |
| 2024-07-18 | -33.17 |
| 2024-07-17 | -33.34 |
| 2024-07-16 | -33.63 |
| 2024-07-15 | -34.04 |
| 2024-07-12 | -33.23 |
| 2024-07-11 | -33.46 |
| 2024-07-10 | -32.76 |
| 2024-07-09 | -32.41 |
| 2024-07-08 | -33.23 |
| 2024-07-05 | -33.05 |
| 2024-07-04 | -33.05 |
| 2024-07-03 | -33.40 |
| 2024-07-02 | -33.23 |
| 2024-06-28 | -32.94 |
| 2024-06-27 | -32.53 |
| 2024-06-26 | -31.83 |
| 2024-06-25 | -31.72 |
| 2024-06-24 | -31.60 |
| 2024-06-21 | -31.54 |
| 2024-06-20 | -31.43 |
| 2024-06-19 | -31.66 |
| 2024-06-18 | -31.54 |
| 2024-06-17 | -31.95 |
| 2024-06-14 | -33.11 |
| 2024-06-13 | -33.34 |
| 2024-06-12 | -34.04 |
| 2024-06-11 | -33.34 |
| 2024-06-10 | -33.75 |
| 2024-06-07 | -34.04 |
| 2024-06-06 | -34.10 |
| 2024-06-05 | -34.10 |
| 2024-06-04 | -33.28 |
| 2024-06-03 | -34.10 |
| 2024-05-31 | -34.85 |
| 2024-05-30 | -33.63 |
| 2024-05-29 | -34.91 |
| 2024-05-28 | -34.45 |
| 2024-05-27 | -34.85 |
| 2024-05-24 | -34.85 |
| 2024-05-23 | -34.62 |
| 2024-05-22 | -34.85 |
| 2024-05-21 | -35.26 |
| 2024-05-17 | -35.49 |
| 2024-05-16 | -35.67 |